MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

IMMP Immutep Limited Forecast, Technical & Fundamental Analysis

a developer of anti-cancer therapeutics

Industry Biotechnology
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

IMMP is expected to report earnings to fall 13.50% to -15 cents per share on August 30

Immutep Limited IMMP Stock Earnings Reports
Q2'22
Est.
$-0.16
Q4'23
Missed
by $0.05
Q2'23
Est.
$-0.15
Q4'22
Beat
by $0.01
The last earnings report on February 27 showed earnings per share of -18 cents, missing the estimate of -13 cents. With 102.48K shares outstanding, the current market capitalization sits at 340.41M.
A.I. Advisor
published General Information

General Information

a developer of anti-cancer therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
24
Web
https://www.immutep.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

IMMP and Stocks

Correlation & Price change

A.I.dvisor tells us that IMMP and XFOR have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMP and XFOR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
-3.80%
XFOR - IMMP
33%
Poorly correlated
-5.80%
CGEN - IMMP
30%
Poorly correlated
-8.57%
SVRA - IMMP
27%
Poorly correlated
-1.41%
CRVS - IMMP
26%
Poorly correlated
-9.82%
CALC - IMMP
25%
Poorly correlated
+7.67%
More

Groups containing IMMP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
-3.80%
australia
theme (10 stocks)
22%
Poorly correlated
+3.00%
drugs
theme (265 stocks)
16%
Poorly correlated
+5.37%
biotechnology
theme (248 stocks)
16%
Poorly correlated
+5.56%
cancer
theme (87 stocks)
13%
Poorly correlated
+0.89%
therapeutics
theme (57 stocks)
12%
Poorly correlated
+20.54%